Inogen Inc

In a Stage 2 advancing environment, the recent Momentum Breakout above minor resistance confirms fresh demand and underpins a bullish medium-term bias. Price is riding above rising 9 and 21 EMAs and has just cleared the ~6.80 resistance zone on strong volume. Short-term momentum favors continuation, though Extreme Overbought conditions warrant cautious management. Execution favors immediate participation in the breakout zone or a shallow pullback into the rising EMAs for continuation exposure.

• ↑Q1 2026 revenue up 5.5% YoY to $82.3M, driven by product sales
• ↑Adjusted EBITDA turned positive at $36K vs. –$7.6M prior year
• ↓Direct-to-consumer sales fell 21.1% YoY to $15.8M, weakening core growth